Tohoku Chemical Co., Ltd. (TYO:7446)
Japan · Delayed Price · Currency is JPY 4,395.00
0.00 (0.00%)
Aug 5, 2026, 3:22 PM JST
Tohoku Chemical Financials Overview
Financials in millions JPY. Fiscal year is October - September.
Millions JPY. Fiscal year is Oct - Sep.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Revenue Revenue Growth | 35,576 | 34,442 | 32,155 | 35,094 | 37,333 | 36,221 |
Revenue Growth | 4.40% | 7.11% | -8.38% | -6.00% | 3.07% | 16.69% |
Gross Profit Gross Profit Growth | 3,504 | 3,285 | 3,139 | 3,344 | 3,472 | 3,174 |
Operating Income Operating Income Growth | 772 | 518 | 340 | 751 | 944 | 713 |
Net Income Net Income Growth | 594 | 428 | 237 | 556 | 657 | 516 |
Earnings Per Share EPS Growth | 659.31 | 475.04 | 263.04 | 617.08 | 728.08 | 564.12 |
EPS Growth | 44.53% | 80.60% | -57.37% | -15.25% | 29.07% | 39.49% |
| Fiscal Year | FY 2025 | FY 2024 |
|---|---|---|
| Period Ending | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 |
Academia/Life Sciences Academia/Life Sciences Growth | 2,439 | 1,932 |
Medical Medical Growth | 14,144 | 14,125 |
Industry Industry Growth | 17,859 | 16,099 |
Total Total Growth | 34,443 | 32,156 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Cash & Investments Cash & Investments Growth | 4,120 | 924 | 763 | 2,195 | 1,407 | 799 |
Total Debt Total Debt Growth | 753 | 812 | 781 | 574 | 594 | 712 |
Net Cash (Debt) Net Cash Growth | 3,367 | 112 | -18 | 1,621 | 813 | 87 |
Net Cash Growth | 463.04% | - | - | 99.39% | 834.48% | - |
Net Cash Per Share Net Cash Per Share Growth | 3737.21 | 124.31 | -19.98 | 1799.07 | 900.95 | 95.11 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | - | 149 | -1,043 | 1,268 | 886 | 322 |
Capital Expenditures CapEx Growth | - | -20 | -64 | -101 | -24 | -31 |
Free Cash Flow Free Cash Flow Growth | - | 129 | -1,107 | 1,167 | 862 | 291 |
Free Cash Flow Growth | - | - | - | 35.38% | 196.22% | -25.00% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Gross Margin | 9.85% | 9.54% | 9.76% | 9.53% | 9.30% | 8.76% |
Operating Margin | 2.17% | 1.50% | 1.06% | 2.14% | 2.53% | 1.97% |
Pretax Margin | 2.43% | 1.85% | 1.18% | 2.29% | 2.61% | 2.06% |
Profit Margin | 1.67% | 1.24% | 0.74% | 1.58% | 1.76% | 1.43% |
FCF Margin | - | 0.38% | -3.44% | 3.33% | 2.31% | 0.80% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 6, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Dividend Per Share Dividend Per Share Growth | 105.000 | 105.000 | 105.000 | 105.000 | 115.000 | 105.000 |
Dividend Per Share Growth | -16.00% | 0% | 0% | -8.70% | 9.52% | 16.67% |
Dividend Yield | 2.31% | 2.62% | 3.01% | 2.99% | 3.89% | 3.43% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 6, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
PE Ratio | 6.67 | 8.44 | 13.71 | 6.04 | 4.42 | 6.10 |
P/FCF Ratio | 1.71 | 28.01 | - | 2.88 | 3.37 | 10.81 |
PS Ratio | 0.11 | 0.11 | 0.10 | 0.10 | 0.08 | 0.09 |